SNOA

$1.14+3.64%visit website

Sonoma Pharmaceuticals, Inc.

Market Cap

$5M

Live price × SEC shares (Aug 6, 2026)

Sector

Health Care

Industry

Pharmaceuticals

Beta (raw)

1.33

60mo monthly vs SPY

P/E (TTM)

N/M

TTM to Jun 2026 · negative earnings

P/S (TTM)

0.2

TTM to Jun 2026 · revenue

P/B

0.8

Mkt cap / shareholders' equity

EV/EBITDA (TTM)

—

EV / TTM EBITDA

Loading…

Financial Statements

USD thousands	Q2 FY2026 Sep 30, 2025	Q3 FY2026 Dec 31, 2025	Q4 FY2026 Mar 31, 2026	Q1 FY2027 Jun 30, 2026	TTM Jun 30, 2026
Revenue	5,604	4,349	5,561	6,406	21,920
Cost of revenue	3,484	2,699	3,380	3,829	13,392
Gross profit	2,120	1,650	2,181	2,577	8,528
Research & development	575	557	545	597	2,274
Selling, general & administrative	1,882	1,771	1,987	2,020	7,660
Total operating expenses	2,457	2,328	2,532	2,617	9,934
Operating income	(337)	(678)	(351)	(40)	(1,406)
Pretax income	(731)	(949)	(497)	(330)	(2,507)
Income tax	(197)	(130)	84	0	(243)
Net income	(534)	(819)	(581)	(330)	(2,264)
EPS (basic) ($)	(0.32)	(0.48)		(0.09)	(1.22)
EPS (diluted) ($)	(0.32)	(0.48)		(0.09)	(1.22)
Weighted avg. shares (basic)	1,646	1,713		3,846
Weighted avg. shares (diluted)	1,646	1,713		3,846

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Aug 6, 2026, period ended Jun 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 61 more quarters, back to Jun 2010, with Tormere Pro.

Corporate Events (8-K)

9 filings in 12 months · 0 with priority itemsFull history →

Filed	Items	Filing
Oct 6, 2026 accepted 8:30 PM ET	1.01Material agreement3.03Holder rights modified5.03Bylaws / fiscal year	Document SEC ↗
Sep 17, 2026 accepted 10:11 PM ET	5.07Shareholder vote	Document SEC ↗
Aug 19, 2026 accepted 9:27 PM ET	5.07Shareholder vote	Document SEC ↗
Jun 18, 2026 accepted 8:33 PM ET	8.01Other events	Document SEC ↗
Apr 30, 2026 accepted 9:00 PM ET	1.01Material agreement8.01Other events	Document SEC ↗
Apr 9, 2026 accepted 12:30 PM ET	1.01Material agreement	Document SEC ↗
Jan 28, 2026 accepted 9:01 PM ET	5.02Officer / director change	Document SEC ↗
Jan 12, 2026 accepted 1:30 PM ET	8.01Other events	Document SEC ↗
Jan 2, 2026 accepted 10:18 PM ET	5.02Officer / director change	Document SEC ↗
Oct 23, 2025 accepted 9:00 PM ET	5.02Officer / director change	Document SEC ↗